Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Molecular mechanisms of diabetes reversibility after bariatric surgery.

Rosa G, Mingrone G, Manco M, Euthine V, Gniuli D, Calvani R, Calvani M, Favuzzi AM, Castagneto M, Vidal H.

Int J Obes (Lond). 2007 Sep;31(9):1429-36. Epub 2007 May 22.

PMID:
17515913
2.

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, Nanni G, Castagneto M, Calvani M, Mingrone G.

Diabetes. 2006 Jul;55(7):2025-31.

3.

Decreased muscle acetyl-coenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects.

Rosa G, Manco M, Vega N, Greco AV, Castagneto M, Vidal H, Mingrone G.

Obes Res. 2003 Nov;11(11):1306-12.

4.

Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion.

Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E.

Diabetes. 2002 Jan;51(1):144-51.

5.

Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery.

Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK.

Diabetes. 2003 May;52(5):1098-103.

6.

Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients.

Rosa G, Di Rocco P, Manco M, Greco AV, Castagneto M, Vidal H, Mingrone G.

Obes Res. 2003 Feb;11(2):176-82.

8.

beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss.

Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G, Ferrannini E.

Diabetes. 2005 Aug;54(8):2382-9.

9.

Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery.

Mingrone G, Manco M, Iaconelli A, Gniuli D, Bracaglia R, Leccesi L, Calvani M, Nolfe G, Basu S, Berria R.

Obesity (Silver Spring). 2008 Aug;16(8):1831-7. doi: 10.1038/oby.2008.297. Epub 2008 Jun 5.

10.

Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.

Mingrone G, DeGaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, Gasbarrini G.

Diabetologia. 1997 May;40(5):599-605.

PMID:
9165230
11.

Body composition and energy expenditure after weight loss following bariatric surgery.

Benedetti G, Mingrone G, Marcoccia S, Benedetti M, Giancaterini A, Greco AV, Castagneto M, Gasbarrini G.

J Am Coll Nutr. 2000 Apr;19(2):270-4.

PMID:
10763909
12.

Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.

Mingrone G.

Nutr Metab Cardiovasc Dis. 2008 Oct;18(8):574-9. doi: 10.1016/j.numecd.2008.07.004.

PMID:
18790374
13.

Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.

Gumbs AA, Modlin IM, Ballantyne GH.

Obes Surg. 2005 Apr;15(4):462-73. Review.

PMID:
15946423
14.

Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion.

Briatore L, Salani B, Andraghetti G, Danovaro C, Sferrazzo E, Scopinaro N, Adami GF, Maggi D, Cordera R.

Obesity (Silver Spring). 2008 Jan;16(1):77-81. doi: 10.1038/oby.2007.9.

15.

Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery.

Mingrone G, Castagneto-Gissey L.

Diabetes Metab. 2009 Dec;35(6 Pt 2):518-23. doi: 10.1016/S1262-3636(09)73459-7. Review.

PMID:
20152737
16.

Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon?

Manco M, Fernández-Real JM, Valera-Mora ME, Déchaud H, Nanni G, Tondolo V, Calvani M, Castagneto M, Pugeat M, Mingrone G.

Diabetes Care. 2007 Jun;30(6):1494-500.

PMID:
17526821
17.

Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery.

Manco M, Calvani M, Nanni G, Greco AV, Iaconelli A, Gasbarrini G, Castagneto M, Mingrone G.

Obes Res. 2005 Oct;13(10):1692-700.

18.

First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G.

Diabetes Care. 2009 Mar;32(3):375-80. doi: 10.2337/dc08-1314. Epub 2008 Nov 25.

19.

Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity.

Briatore L, Salani B, Andraghetti G, Maggi D, Adami GF, Scopinaro N, Cordera R.

Obesity (Silver Spring). 2010 May;18(5):932-6. doi: 10.1038/oby.2010.28. Epub 2010 Feb 25.

20.

What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?

Andreelli F, Amouyal C, Magnan C, Mithieux G.

Diabetes Metab. 2009 Dec;35(6 Pt 2):499-507. doi: 10.1016/S1262-3636(09)73456-1. Review.

PMID:
20152734

Supplemental Content

Support Center